Zhengye Biotechnology Holding Limited

US$1.50As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:UPCHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (3.50%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM —
TSR TTM (39.02%)
Mkt cap US$71.09M
ROIC (5.78%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.66
10.66%
(92.01%)
Hold 8|2|9|12|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.02
0.02
0.02
0.02
6.60%
19.61%
20.64%
19.51%
Revenue¥M
4.983
4.931
5.193
5.202
2.01%
(1.71%)
4.42%
3.97%
Peers (US$6.984M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.194
(0.040)
(0.038)
EBIT/Intx
0.744
0.386
0.386
Own earn%
6.42
(160.56)
(107.86)
Sh yield%
31.04
38.82
37.48
Owners
Insiders/Inst%
0.23
32.42
Short interest%
2.06
SBC / revenue%
3.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
18–25
$1 testx
0.3
Incr. ROIC%
13